Cargando…
Thrombosis and Coagulopathy in COVID-19
Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) which initially occurred in the city of Wuhan, located in China's Hubei province, spread around the world and on March 11, 2020, the World Health Organization declared the new Coronavirus disease 2019 (COVID-19) as a pandem...
Autores principales: | Gómez-Mesa, Juan Esteban, Galindo-Coral, Stephania, Montes, Maria Claudia, Muñoz Martin, Andrés J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby-Year Book
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605852/ https://www.ncbi.nlm.nih.gov/pubmed/33243440 http://dx.doi.org/10.1016/j.cpcardiol.2020.100742 |
Ejemplares similares
-
Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry
por: Gómez-Mesa, Juan Esteban, et al.
Publicado: (2021) -
COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020) -
Thrombosis and coagulopathy in COVID‐19: An illustrated review
por: Levi, Marcel, et al.
Publicado: (2020) -
COVID-19 associated coagulopathy and thrombosis in cancer
por: Levi, Marcel, et al.
Publicado: (2022) -
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
por: Miesbach, Wolfgang, et al.
Publicado: (2020)